Sotera Health (NASDAQ:SHC) Director Gtcr Investment Xi Llc Sells 12,735,301 Shares of Stock

Sotera Health Company (NASDAQ:SHC) Director Gtcr Investment Xi Llc sold 12,735,301 shares of the stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total value of $193,194,516.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Gtcr Investment Xi Llc also recently made the following trade(s):

• On Friday, March 6th, Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock. The stock was sold at an average price of $15.27, for a total value of $152,700,000.00.

Sotera Health Stock Down 1.4%

Shares of SHC stock opened at $15.27 on Friday. The stock has a market cap of $4.35 billion, a P/E ratio of 37.24 and a beta of 1.82. Sotera Health Company has a one year low of $10.80 and a one year high of $19.85. The stock has a fifty day moving average price of $14.88 and a 200 day moving average price of $16.43. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. The company had revenue of $280.05 million during the quarter, compared to analysts’ expectations of $270.78 million. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The business’s revenue was up 10.0% on a year-over-year basis. During the same period last year, the business earned $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Analysts predict that Sotera Health Company will post 0.86 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have recently weighed in on SHC shares. Barclays lowered their target price on Sotera Health from $20.00 to $18.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Wall Street Zen lowered Sotera Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 11th. Citigroup raised their target price on Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a report on Tuesday, February 24th. Zacks Research cut Sotera Health from a “strong-buy” rating to a “hold” rating in a report on Friday, January 30th. Finally, Piper Sandler restated an “overweight” rating and set a $22.00 target price (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Seven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $20.33.

Hedge Funds Weigh In On Sotera Health

Several institutional investors have recently modified their holdings of SHC. IFP Advisors Inc lifted its holdings in shares of Sotera Health by 1,105.6% during the 4th quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock valued at $26,000 after purchasing an additional 1,371 shares in the last quarter. Rothschild Investment LLC bought a new position in shares of Sotera Health during the 4th quarter valued at about $27,000. Root Financial Partners LLC lifted its stake in Sotera Health by 217.5% in the 1st quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock valued at $30,000 after acquiring an additional 1,455 shares in the last quarter. True Wealth Design LLC lifted its stake in Sotera Health by 389.3% in the 4th quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock valued at $32,000 after acquiring an additional 1,456 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its stake in Sotera Health by 831.4% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock valued at $37,000 after acquiring an additional 2,935 shares in the last quarter. Institutional investors own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.